Zacks Research Has Optimistic Outlook of RLI Q1 Earnings

RLI Corp. (NYSE:RLIFree Report) – Analysts at Zacks Research boosted their Q1 2027 EPS estimates for shares of RLI in a research report issued on Tuesday, August 11th. Zacks Research analyst Team now expects that the insurance provider will post earnings of $0.77 per share for the quarter, up from their prior forecast of $0.74. The consensus estimate for RLI’s current full-year earnings is $2.88 per share. Zacks Research also issued estimates for RLI’s FY2027 earnings at $2.72 EPS.

Other research analysts have also issued research reports about the company. Weiss Ratings raised RLI from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, July 29th. UBS Group set a $74.00 target price on shares of RLI in a research note on Tuesday, July 28th. Wells Fargo & Company cut shares of RLI from an “equal weight” rating to an “underweight” rating and set a $57.00 price target for the company. in a report on Wednesday, July 29th. Keefe, Bruyette & Woods reiterated an “outperform” rating and set a $74.00 target price (up from $70.00) on shares of RLI in a research report on Tuesday, July 28th. Finally, Wall Street Zen upgraded RLI from a “sell” rating to a “hold” rating in a research note on Saturday, August 1st. One research analyst has rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $63.00.

Get Our Latest Stock Analysis on RLI

RLI Stock Down 1.8%

NYSE RLI opened at $62.76 on Thursday. The business’s 50-day moving average price is $58.92 and its 200 day moving average price is $57.70. The firm has a market cap of $5.76 billion, a P/E ratio of 13.18 and a beta of 0.38. RLI has a 52-week low of $47.26 and a 52-week high of $69.19.

RLI (NYSE:RLIGet Free Report) last issued its quarterly earnings results on Wednesday, July 22nd. The insurance provider reported $0.83 earnings per share for the quarter, topping analysts’ consensus estimates of $0.72 by $0.11. RLI had a net margin of 22.22% and a return on equity of 17.61%. The firm had revenue of $575.57 million during the quarter, compared to analysts’ expectations of $568.70 million. During the same quarter in the prior year, the business earned $0.82 EPS. RLI’s quarterly revenue was up 15.2% compared to the same quarter last year.

Institutional Investors Weigh In On RLI

A number of large investors have recently bought and sold shares of RLI. Royal Bank of Canada lifted its position in shares of RLI by 115.1% in the first quarter. Royal Bank of Canada now owns 56,386 shares of the insurance provider’s stock valued at $4,529,000 after acquiring an additional 30,170 shares in the last quarter. Goldman Sachs Group Inc. raised its stake in RLI by 110.8% in the 1st quarter. Goldman Sachs Group Inc. now owns 185,504 shares of the insurance provider’s stock valued at $14,902,000 after purchasing an additional 97,501 shares during the last quarter. Empowered Funds LLC lifted its holdings in RLI by 472.3% in the 1st quarter. Empowered Funds LLC now owns 29,177 shares of the insurance provider’s stock valued at $2,344,000 after purchasing an additional 24,079 shares in the last quarter. EverSource Wealth Advisors LLC lifted its holdings in RLI by 46.2% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,559 shares of the insurance provider’s stock valued at $113,000 after purchasing an additional 493 shares in the last quarter. Finally, Amundi boosted its stake in shares of RLI by 16,550.0% during the 2nd quarter. Amundi now owns 23,976 shares of the insurance provider’s stock worth $1,689,000 after purchasing an additional 23,832 shares during the last quarter. Institutional investors and hedge funds own 77.89% of the company’s stock.

Insider Buying and Selling at RLI

In other RLI news, Director Clark C. Kellogg acquired 3,000 shares of the stock in a transaction that occurred on Monday, June 1st. The shares were purchased at an average cost of $50.90 per share, with a total value of $152,700.00. Following the purchase, the director owned 4,502 shares in the company, valued at approximately $229,151.80. The trade was a 199.73% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director David B. Duclos bought 2,500 shares of the business’s stock in a transaction on Thursday, May 28th. The shares were acquired at an average price of $51.99 per share, with a total value of $129,975.00. Following the transaction, the director owned 9,780 shares of the company’s stock, valued at $508,462.20. The trade was a 34.34% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have acquired 16,500 shares of company stock valued at $858,955 over the last 90 days. 2.39% of the stock is currently owned by corporate insiders.

Key RLI News

Here are the key news stories impacting RLI this week:

  • Positive Sentiment: Zacks raised its FY2026 EPS forecast to $2.84 from $2.70, close to the current consensus estimate of $2.85. It also increased its FY2027 forecast to $2.72 from $2.64 and FY2028 to $2.73 from $2.51, signaling improved expectations for RLI’s longer-term profitability. RLI earnings estimate revisions
  • Positive Sentiment: Several quarterly estimates were raised, including Q4 2026 EPS to $0.67 from $0.64, Q4 2027 to $0.70 from $0.62, Q1 2027 to $0.77 from $0.74, and Q2 2028 to $0.79 from $0.71. These upgrades support the view that underwriting and investment performance could remain resilient. RLI quarterly earnings estimate revisions
  • Neutral Sentiment: The most recent revisions do not represent a new company announcement or change in guidance; they are analyst-model updates. RLI’s latest reported quarter had already exceeded expectations, with EPS of $0.83 versus a $0.72 consensus and revenue up 15.2% year over year.
  • Negative Sentiment: Zacks lowered its Q3 2026 EPS forecast to $0.51 from $0.53 and Q2 2027 to $0.67 from $0.69. Those reductions point to some expected earnings pressure in upcoming periods and may be contributing to the weaker share performance.

About RLI

(Get Free Report)

RLI Corporation (NYSE:RLI) is a specialty property and casualty insurance company focused on underwriting niche risks for businesses and individuals. Headquartered in Peoria, Illinois, the company operates through a network of independent agents and brokers, offering customized coverage solutions. RLI’s approach emphasizes disciplined underwriting, targeted product development and strong customer service to maintain profitability and long-term growth.

Founded in 1965 as Replacement Lens, Inc, RLI initially provided insurance for contact lens manufacturers before shifting its focus to specialty insurance in the 1980s.

Further Reading

Earnings History and Estimates for RLI (NYSE:RLI)

Receive News & Ratings for RLI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RLI and related companies with MarketBeat.com's FREE daily email newsletter.